Comparison

CL-197 European Partner

€9,150.00
Excl. VAT
Item no. HY-148191-100mg
Manufacturer MedChem Express
CASRN 1030595-07-3
Amount 100 mg
Category
Type Inhibitors
Specific against other
Purity 99.32
Formula C12H11F2N5O3
Citations [1]Hou J, et al. 4'-Ethynyl-2'-deoxy-2'-β-fluoro-2-fluoroadenosine: A Highly Potent and Orally Available Clinical Candidate for the Treatment of HIV-1 Infection. J Med Chem. 2023 Aug 24;66(16):11282-11293.
Smiles O[C@H]1[C@H](F)[C@H](N2C=NC3=C(N)N=C(F)N=C32)O[C@@]1(CO)C#C
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Available
Product Description
CL-197 is an orally active and long-acting purine anti-HIV nucleoside reverse transcriptase inhibitor (NRTI). CL-197 has potential effect on the research of viral, oncological and cerebrovascular diseases[1]. CL-197 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
StorageTemperature
-20°C, 3 years; 4°C, 2 years (Powder)
Shipping
Room Temperature
Manufacturers Applications
COVID-19-anti-virus
Molecular Weight
311.24
Clinical Information
Phase 1
Solubility
DMSO : 100 mg/mL (ultrasonic)
Pathway
Anti-infection; Metabolic Enzyme/Protease
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
Listprice: €9,150.00
Price: €9,150.00
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close